US FDA approval for Generic Version of Zetia Tablets made Sun Pharma top gainer

  • News
  • June 16, 2017

New Delhi : BSE Shares of Sun Pharmaceutical up 2.87 percent on the back of USFDA approval for ezetimibe tablets. Sun’s wholly owned subsidiary has finally got approved by the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for a generic version of Zetia, (ezetimibe) tablets 10mg.

Ezetimibe, generic version of Zetia will be used to lower cholesterol in the blood. According to market reports Zetia has $2.7 billion of the market in the US and this success is very progressive for Sun Pharmaceutical Company.

Ezetimibe works by reducing the amount of cholesterol absorbance in an individual’s body from the diet. Sun Pharma is under performing and one-year performance is 28.04 percent down.

Zydus Cadila has also received the final US FDA approval to market ezetimibe tablets USP, 10 mg, used to reduce high cholesterol levels. The estimated sale for ezetimibe tablets is $2.7 billion as per IMS MAT April 2017.

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines